The fund will provide capital for MIT-founded Gingko's own spinouts and has attracted LPs including Viking Global Investors, General Atlantic and Cascade Investment.
Ginkgo Bioworks, a US-based microbe engineering spinout of Massachusetts Institute of Technology, unveiled a $350m investment vehicle called Ferment Consortium yesterday that will finance its spinouts.
Ferment Consortium is funded by Gingko’s “major investors,” the company said, identifying hedge fund manager Viking Global Investors, growth equity firm General Atlantic and investment holding company Cascade Investment as backers.
Founded in 2009, Ginkgo has built a biotechnology platform to grow organisms with industrial applications, spanning areas such as consumer goods, nutrition,…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
